PURPOSE: Central retinal vein occlusion (CRVO) entails retinal hypoxia that often causes visual impairment. It has been shown that oxygen saturation in larger retinal vessels correlates with the visual acuity at the time of diagnosis of CRVO but has no predictive value for the visual outcome in patients treated with anti-VEGF medication after 3 months. However, assessing the predictive value of retinal oxygen saturation after 12 months is essential because this is when the main restitution after CRVO occurs. METHODS: Retinal oximetry was performed in 117 patients referred with CRVO to three European centres. The correlation between oxygen saturation and visual acuity at baseline and the predictive value of oxygen saturation in larger retinal vessels for the 12-month visual outcome after treatment with anti-VEGF medication were studied. RESULTS: In the affected eye, the oxygen saturation was significantly higher in the arterioles, significantly lower in the venules, and the arterio-venous (A-V) significantly higher than in the unaffected eye (p < 0.001 for all comparisons). Correlations between best-corrected visual acuity (BCVA) and oxygen saturations were moderate and negative for arterioles (p < 0.001), positive for venules (p = 0.03) and negative for the A-V difference (p = 0.001). Best-corrected visual acuity (BCVA), but not oxygen saturation or the other explanatory variables at baseline, contributed significantly to predicting BCVA after 12 months. CONCLUSION: Retinal vessel oxygen saturation is affected in CRVO, and saturation correlates with BCVA. However, retinal oximetry cannot replace measures of visual function as a predictor of visual outcome after 12 months of anti-VEGF treatment for CRVO.

Department of Ophthalmology Aarhus University Hospital Aarhus N Denmark

Department of Ophthalmology and Physiology University of Iceland Reykjavik Iceland

Department of Ophthalmology Faculty of Medicine and dentistry Palacký University Olomouc Olomouc Czech Republic

Department of Ophthalmology Military University Hospital Prague 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Asraf M, Souka AAR & Singh RP (2016): Central retinal vein occlusion: modifying current treatment protocols. Eye 30(4): 505-514.

Beach JM, Schwenzer KJ, Srinivas S, Kim D & Tiedeman JS (1999): Oximetry of retinal vessels by dual-wavelength imaging: calibration and influence of pigmentation. J Appl Physiol 86: 748-758.

Bek T (2013): Regional morphology and pathophysiology of retinal vascular disease. Prog Retin Eye Res 36: 247-259.

Campa C, Alivernini G, Bolletta E, Parodi MB & Perri P (2016): Anti-VEGF therapy for retinal vein occlusions. Curr Drug Targets 17: 328-336.

Geirsdottir A, Palsson O, Hardarson SH, Olafsdottir OB, Kristjansdottir JV & Stefansson E (2012): Retinal vessels oxygen saturation in healthy individuals. Invest Ophthalmol Vis Sci 53: 5433-5442.

Hayreh SS, Podhajsky PA & Zimmerman MB (2011): Natural history of visual outcome in central retinal vein occlusion. Ophthalmology 118(1): 119-133.

Jakobsen NS, Larsen DA & Bek T (2018): The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema. Acta Ophthalmol 96(7): 744-748.

Jeppesen SK & Bek T (2017): Retinal oxygen saturation correlates with visual acuity but does not predict outcome after anti-VEGF treatment in central retinal vein occlusion. Invest Ophthalmol Vis Sci 58(5): 2498-2502.

Jeppesen SK & Bek T (2019): The retinal oxygen saturation measured by dual wavelength oximetry in larger retinal vessels is influenced by the linear velocity of the blood. Curr Eye Res 44(1): 46-52.

Jørgensen C & Bek T (2014): Increasing oxygen saturation in larger retinal vessels after photocoagulation for diabetic retinopathy. Invest Ophthalmol Vis Sci 55(8): 5365-5369.

Jørgensen CM, Hardarson SH & Bek T (2014): The oxygen saturation in retinal vessels from diabetic patients depends on the severity and type of vision-threatening retinopathy. Acta Ophthalmol 92(1): 34-39.

Lashay A, Riazi-Esfahani H, Mirghorbani M & Yaseri M (2019): Intravitreal medications for retinal vein occlusion: systematic review and meta-analysis. J Ophthalmic Vis Res 14(3): 336-366.

Nourinia R, Emamverdi M, Ramezani A, Amizadeh Y, Khorshidifar M, Behnaz N & Safi S (2020): Peripheral ischemic retinal photocoagulation in addition to intravitreal bevacizumab versus intravitreal bevacizumab alone for the treatment of macular edema secondary to central retinal vein occlusion: A randomized double-masked controlled clinial trial. Retina 40(6): 1110-1117.

Sander B, Al-Abiji HA, Kofod M & Jørgensen TM (2015): Do different spectral domain OCT hardwares measure the same? Comparison of retinal thickness using third-party software. Graefes Arch Clin Exp Ophthalmol. 253(11): 1915-1921.

Traustason S, la Cour M & Larsen M (2014): Retinal vascular oximetry during ranibizumab treatment of central retinal vein occlusion. Br J Ophthalmol. 98: 1208-1211.